Back

High-sensitivity cardiac troponin and the universal definition of myocardial infarction: a randomised controlled trial

31 August 2019 (11:54 - 12:12)
Organised by:
Congress Presentation Part of: High sensitivity troponins in patients with suspected acute coronary syndromes Epidemiology, Prognosis, Outcome ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Andrew Chapman

Royal Infirmary of Edinburgh, Edinburgh (United Kingdom of Great Britain & Northern Ireland)

4 More presentations in this session

Presentation thumbnail
State of the Art - High sensitivity troponins in acute coronary syndromes
Professor C. Mueller (Basel, CH)
Slides Video
Presentation thumbnail
Safety and efficacy of high-sensitivity cardiac troponin for risk stratification in patients with suspected acute coronary syndrome
Doctor A. Bularga (Edinburgh, GB)
Abstract Slides Video
Presentation thumbnail
Real-world Outcome of the ESC 0/1-hour Algorithm when Routinely Applied in Early Presenters
Doctor R. Twerenbold (Hamburg, DE)
Abstract Slides Video
Presentation thumbnail
Diagnosis and management of myocardial injury following non-cardiac surgery: present and future
Professor P. Devereaux (Hamilton, CA)
Slides Video

Access the full session

Session thumbnail
High sensitivity troponins in patients with suspected acute coronary syndromes

The Event

Event poster

ESC Congress 2019

31 August 2019 11:54 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources